Remote Patient Management for Cardiac Implantable Electronic Devices

NOTE: To participate in this study, you must have a permanent pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) that is capable of remote monitoring.

Remote monitoring is in widespread use worldwide, but in Canada, it is used primarily in patients with ICDs, not pacemakers. It is cost-effective and can reduce the detection times of potential cardiac problems.

What is Remote Monitoring Technology?

The remote monitoring technology will communicate with your implantable device using wireless technology. It sends the information from your pacemaker to an application on your phone. That application sends the same information through the internet to the device clinic, reducing the need for frequent in-clinic visits. You will need access to a smartphone or tablet in order for this technology to work.

How is the Study Being Done?

Participants in this study will be randomly placed in one of two groups. Neither you, the study staff nor the investigator(s) can influence which group you are in. You will have a 50 % chance of being placed in either the remote management group (RPM) or the standard of care group (SOC). You and the research team will know which group you are in. In the RPM group, you will test out a new remote monitoring application, called VIRTUES, and only do remote transmissions for the duration of the study. In the SOC group, your care will be unaffected and you will simply be followed by our research team. The length of this study for each participant is 18 months.

null

Study Sponsored By

Nova Scotia Health Authority

Participants Required

More Information

Study ID: NCT03405740